Two year outcomes of "treat and extend" Intravitreal therapy using aflibercept preferentially for neovascular age-related macular degeneration
Daniel Barthelmes*, Vuong Nguyen, Vincent Daien, Anna Campain, Richard Walton, Robyn Guymer, Nigel Morlet, Alex P. Hunyor, Rohan W. Essex, Jennifer J. Arnold, Mark C. Gillies
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
85Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Two year outcomes of "treat and extend" Intravitreal therapy using aflibercept preferentially for neovascular age-related macular degeneration'. Together they form a unique fingerprint.